Edition:
United States

Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

93.68USD
20 Nov 2017
Change (% chg)

$0.38 (+0.41%)
Prev Close
$93.30
Open
$93.30
Day's High
$93.80
Day's Low
$93.03
Volume
416,594
Avg. Vol
709,655
52-wk High
$93.86
52-wk Low
$76.28

Chart for

About

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins,... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $65,164.30
Shares Outstanding(Mil.): 695.61
Dividend: 0.14
Yield (%): 0.60

Financials

  Industry Sector
P/E (TTM): -- 30.95 15.79
EPS (TTM): -- -- --
ROI: -- 10.03 12.01
ROE: -- 15.31 15.91

BRIEF- IDBS says has been acquired by Danaher Corp

* U.K's IDBS says has been acquired by the life sciences platform of Danaher Corp Source text - http://bit.ly/2yYOOLb Further company coverage:

Oct 30 2017

BRIEF-Danaher Q3 adjusted non-GAAP earnings per share $1.00

* Sees Q4 2017 adjusted non-gaap earnings per share $1.12 to $1.16

Oct 19 2017

Hearing-aid maker Sonova names Danaher's Kaldowski as new CEO

ZURICH, Sept 1 Sonova on Friday named Arnd Kaldowski as new chief executive officer as the Swiss company renews leadership following acquisitions and product introductions aimed at protecting its perch as the world's largest hearing aid maker.

Sep 01 2017

BRIEF-Danaher reports Q2 earnings per share $0.79

* Sees Q3 2017 adjusted non-gaap earnings per share $0.92 to $0.96

Jul 20 2017

BRIEF-Danaher announces pricing of euro-denominated senior notes offering

* Danaher announces pricing of euro-denominated senior notes offering

Jun 20 2017

Earnings vs. Estimates